Status not kept up to date
Traditional Versus Progressive Robot-assisted Gait Training in People With Multiple Sclerosis and Severe Gait Disability
NCT06381440 · University Hospital of Ferrara · Updated 24 April 2024
- What is being tested
- Lokomat device (Hocoma AG, Volketswil, Switzerland).; Conventional walking training
- For
- Multiple Sclerosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 65 years. About 24 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 15 Nov 2023, ends 30 Nov 2024. Registered 24 April 2024.
- Results
- None posted yet.
In the researchers' words
Multiple sclerosis (MS) is a demyelinating neurodegenerative disease. Qualitative alterations in walking function in MS people involve 75% of subjects with MS and are determined by reduced coordination, mobility, balance, and increased risk of falling. Robot assisted gait training (RAGT) devices seem effective in MS patients with severe motor disabilities, failing to show significant superiority when compared to intensive overground gait rehabilitation (OGT). This study aims to evaluate the effects of a low-intensity RAGT at progressively increasing intensity compared to conventional RAGT and OGT.
Sites
- Department of Neuroscience and Rehabilitation, University Hospital of FerraraFerrara, Emilia-Romagna, Italy